Chronic myeloid leukemia (CML) is a hematopoietic neoplasm that arises from BCR-ABL1 translocation, originating from a small population of leukemic stem cells with extensive self-renewal capacity and an inflammatory microenvironment. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.